AIM
BEAT

Alambic Investment Management’s BioTelemetry, Inc. BEAT Stock Holding History

Alambic Investment Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-12,500
Closed -$279K – 724
2016
Q4 		$279K Hold
12,500
– – 0.05% 440
2016
Q3 		$232K Sell
12,500
-34,205
-73% -$645K 0.05% 409
2016
Q2 		$761K Buy
46,705
+18,405
+65% +$271K 0.19% 196
2016
Q1 		$331K Buy
+28,300
New +$316K 0.11% 300

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Alambic Investment Management's BEAT Position: Q1 2017 in Review

Alambic Investment Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2017, closing a stake of 12,500 shares — an estimated $279K sold.

Alambic Investment Management first reported a position in BEAT in Q1 2016 and held it in 4 quarters. The position peaked at $761K in Q2 2016. 178 funds tracked by Wall St. Rank hold BEAT as of Q1 2017.

  • Alambic Investment Management reported no remaining BioTelemetry, Inc. position as of Q1 2017 after selling out during the quarter.
  • Alambic Investment Management sold 12,500 BioTelemetry, Inc. shares in Q1 2017, an estimated $279K.
  • Alambic Investment Management first reported a position in BioTelemetry, Inc. in Q1 2016 and held it in 4 quarters.
  • Alambic Investment Management's BioTelemetry, Inc. position peaked at $761K in Q2 2016.
  • 178 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2017.

Based on Alambic Investment Management's 13F filing for Q1 2017, filed 9 May 2017.